Market Overview

Janney Capital Initiates Coverage on Cubist Pharmaceuticals, Inc. at Buy, Announces $50.00 PT

Share:

Latest Ratings for CBST

DateFirmActionFromTo
Dec 2014UBSDowngradesBuyNeutral
Dec 2014RBC CapitalDowngradesOutperformSector Perform
Dec 2014JefferiesDowngradesBuyHold

View More Analyst Ratings for CBST
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (CBST)